Organo Corporation

Organo Corporation

ORGJF
Organo CorporationUS flagOther OTC
89.03
USD
- -
- -
4.09BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,347.43
1,491.88
1,708.76
1,761.05
1,720.51
2,012.76
2,109.16
2,193.5
2,441.7
2,887.43
3,273.96
3,551.83
- -
1,847.61
Basic EPS, GAAP
14.41
23.55
53.94
59.29
60.37
97.11
156.51
154.18
200.66
255.76
376.92
525.37
- -
256.22
Free Cash Flow per Basic Share
153.69
-65.91
-119.39
114.26
-11.34
109.68
165.76
-127.2
174.06
-435.82
45.27
400.52
- -
- -
Dividend per Share
12.5
9.98
9.99
12.48
13.75
14.31
22.88
27.33
33.57
51.17
74.14
132.14
- -
- -
Book Value per Share
814.8
826.9
870.3
738.67
964.1
1,051.22
1,186.76
1,310.53
1,478.15
1,683.86
1,984.37
2,375.74
- -
2,099.46
Tangible Book Value per Share
952.2
973.27
996.35
1,042.71
1,096.79
1,168.88
1,305.59
1,444.03
1,632.36
1,862.53
2,202.73
2,612.12
- -
2,339.27
Basic Weighted Avg Shares
46
46
46
46
46
46
46
46
46
46
46
46
- -
46
Sales/Revenue/Turnover
62,096
68,741
78,719
81,114
79,226
92,273
96,515
100,638
112,069
132,426
150,356
163,269
177,654
84,887
Operating Margin (%)
1.34
3.49
5.02
23
4.82
7.11
10.27
9.52
9.68
11.49
14.99
19.06
21.19
17.3
Depreciation Expense
1,065
999
950
950
972
920
1,189
1,212
1,332
1,824
2,010
1,925
1,981
- -
Net Income, GAAP
664
1,085
2,485
2,731
2,780
4,452
7,162
7,074
9,210
11,730
17,310
24,150
28,401
11,772
Effective Tax Rate (%)
43.05
44.76
34.81
31.08
28.39
30.05
27.19
26.9
27.33
26.63
26.65
25.25
25.86
21.93
Profit Margin (%)
1.07
1.58
3.16
3.37
3.51
4.82
7.42
7.03
8.22
8.86
11.51
14.79
15.99
13.87
Working Capital
26,941
31,063
32,407
32,965
33,333
36,107
43,838
48,953
59,790
68,027
80,867
99,966
121,063
86,387
LT Debt
2,552
4,402
3,801
2,601
1,401
200
2,095
1,495
5,695
3,895
2,400
3,680
6,000
1,800
Total Equity
44,252
45,308
46,567
49,034
51,680
54,795
60,857
67,357
76,004
86,370
102,146
121,193
142,961
108,488
Return on Invested Capital (%)
0.82
2.34
4.18
19.55
4.06
6.64
10.12
8.86
8.83
10.36
12.5
15.99
16.78
8.57
Return on Capital (%)
1.43
2.28
4.67
5.07
5.04
7.37
11.49
10.18
11.62
12.17
14.66
18.7
19.37
9.93
Return on Common Equity (%)
1.77
2.87
6.36
7.37
7.09
9.62
13.97
12.36
14.39
16.17
20.56
24.11
23.83
13.25

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
34,065
- -
24,050
LT Borrowings
2,400
- -
1,800
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
- -
46
Market Capitalization
187,638
65,159
178,309

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
153,469
- -
151,315
Cash, Cash Equivalents & STI
45,456
- -
51,972
Accounts Receivable, Net
44,121
- -
74,558
Inventories
21,830
- -
17,114
Total Current Liabilities
72,602
- -
64,928
Payables & Accruals
- -
- -
- -
ST Debt
34,065
- -
24,050
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.98%
16.27%
17.96%
Free Cash Flow
-145.13%
8.72%
-44.47%
Net Income, GAAP
29.37%
32.45%
17.6%
Sales/Revenue/Turnover
8.65%
12.09%
8.81%
Total Cash Common Dividend
35.61%
47.61%
39.4%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29,612
35,857
40,767
44,120
150,356
2025
- -
- -
- -
- -
163,269
2026
- -
- -
- -
- -
177,654

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
34.8
- -
- -
- -
376.92
2025
- -
- -
- -
- -
525.37
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
74.14
2025
- -
- -
- -
- -
132.14
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Masayuki Yamada
Full Time Employees
2,658
Sector
Industrials
Industry
Industrial - Pollution & Treatment Controls
Address
1-2-8, Shinsuna Tokyo TY Japan 136-8631
IPO Date
Apr 13, 2022
Business
Organo Corporation engages in the water treatment engineering business and functional products business. The company manufactures, sells, maintains, and manages pure water systems, ultrapure water systems, wastewater treatment systems, and condensate demineralizers for power stations; standardized water treatment equipment, water treatment chemicals such as ion exchange resins and activated carbon, and food processing materials; as well as filtration equipment, reverse osmosis membranes, electrodeionization systems, and resource recovery systems for hydrofluoric acid, tetramethylammonium hydroxide, rare metals, and organic solvents. Organo operates primarily in Japan with additional presence in Taiwan, China, Southeast Asia, and other international markets, serving industries including electronics and semiconductors, pharmaceuticals and medical devices, energy, sugar production, water supply, and sewage treatment facilities. Founded on May 1, 1946, the company is headquartered at 1-2-8 Shinsuna, Koto-ku, Tokyo, Japan, and employs approximately 1,266 people as of March 2025. In 2025, Organo announced amendments to its corporate governance guidelines, released full-year FY03/25 financial results, issued notices regarding officer changes and organizational restructuring, and exhibited at the ISPE Facilities of the Future Conference.